Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β

Cytokine

Volumn 61, Issue 2, 2013, Pages 645-655

  de Paus, Roelof A ^a   van Wengen, Annelies ^a   Schmidt, Iris ^a   Visser, Marten ^a   Verdegaal, Els M E ^a   van Dissel, Jaap T ^a   van de Vosse, Esther ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Interferon gamma; Monocytes; PRMT1; STAT; Type I interferons

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD64 ANTIGEN; CYTOKINE; GAMMA INTERFERON RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 23; METHYLTRANSFERASE; RECOMBINANT ALPHA2A INTERFERON; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL INFECTION; CUTANEOUS MELANOMA; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

DOWN-REGULATION; HUMANS; IMMUNITY; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; LIGANDS; MONOCYTES; PHOSPHORYLATION; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN-ARGININE N-METHYLTRANSFERASES; RECEPTORS, IGG; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 84873153069     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.12.005     Document Type: Article

References (35)

1. van de Vosse E., van Dissel J.T., Ottenhoff T.H. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 2009, 9:688-698.
2. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
3. Ottenhoff T.H.M., Hari Dass R., Yang N., Zhang M., Wong H.E.E., Sahiratmadja E., et al. Genome-wide expression profiling identifies type I interferon response pathways in active tuberculosis. Plos One 2012, 7:e45839.
4. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β. Proc Natl Acad Sci USA 2001, 98:5752-5757.
5. Manca C., Tsenova L., Freeman S., Barczak A.K., Tovey M., Murray P.J., et al. Tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 2005, 25:694-701.
6. Spensieri F., Fedele G., Fazio C., Nasso M., Stefanelli P., Mastrantonio P., et al. Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immunol 2006, 74:2831-2838.
7. Bauler T.J., Chase J.C., Bosio C.M. IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis. J Immunol 2011, 187:1845-1855.
8. Sanda C., Weitzel P., Tsukahara T., Schaley J., Edenberg H.J., Stephens M.A., et al. Differential gene induction by type I and type II interferons and their combination. J Interferon Cytokine Res 2006, 26:462-472.
9. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell Microbiol 2006, 8:907-922.
10. Seo Y.J., Hahm B. Type I interferon modulates the battle of host immune system against viruses. Adv Appl Microbiol 2010, 73:83-101.
11. Opitz B., Vinzing M., van Laak V., Schmeck B., Heine G., Gunther S., et al. Legionella pneumophila induces IFN-β in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem 2006, 281:36173-36179.
12. Nagai T., Devergne O., van Seventer G.A., van Seventer J.M. Interferon-β mediates opposing effects on interferon-γ-dependent interleukin-12 p70 secretion by human monocyte-derived dendritic cells. Scand J Immunol 2007, 65:107-117.
13. van de Wetering D., Van Wengen A., Savage N.D., van de Vosse E., van Dissel J.T. IFN-α cannot substitute lack of IFN-γ responsiveness in cells of an IFN-γR1 deficient patient. Clin Immunol 2011, 138:282-290.
14. Shahangian A., Chow E.K., Tian X., Kang J.R., Ghaffari A., Liu S.Y., et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009, 119:1910-1920.
15. O'Connell R.M., Saha S.K., Vaidya S.A., Bruhn K.W., Miranda G.A., Zarnegar B., et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 2004, 200:437-445.
16. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-γ. Annu Rev Immunol 1997, 15:749-795.
17. Qureshi S.A., Salditt-Georgieff M., Darnell J.E. Tyrosine-phosphorylated STAT1 and STAT2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc Natl Acad Sci USA 1995, 92:3829-3833.
18. Fultz M.J., Vogel S.N. Analysis of the antagonist effect of IFN-α on IFN-γ-induced interferon consensus sequence binding protein messenger RNA in murine macrophages. J Inflammation 1998, 48:28-39.
19. Abramovich C., Yakobson B., Chebath J., Revel M. A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNαR1 chain in the type I interferon receptor. EMBO J 1997, 16:260-266.
20. Altschuler L., Wook J.O., Gurari D., Chebath J., Revel M. Involvement of receptor-bound protein methyltransferase PRMT1 in antiviral and antiproliferative effects of type I interferons. J Interferon Cytokine Res 1999, 19:189-195.
21. Lee Y.H., Stallcup M.R. Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation. Mol Endocrinol 2009, 23:425-433.
22. Mowen K.A., Tang J., Zhu W., Schurter B.T., Shuai K., Herschman H.R., et al. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 2001, 104:731-741.
23. Liu B., Mink S., Wong K.A., Stein N., Getman C., Dempsey P.W., et al. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat Immunol 2004, 5:891-898.
24. Verdegaal E.M., Visser M., Ramwadhdoebe T.H., van der Minne C.E., van Steijn J.A., Kapiteijn E., et al. Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-α. Cancer Immunol Immunother 2011, 60:953-963.
25. de Paus R.A., Kilic S.S., van Dissel J.T., van de Vosse E. Effect of amino acid substitutions in the human IFN-γR2 on IFN-γ responsiveness. Genes Immunol 2011, 12:136-144.
26. Feng Y., Xie N., Wu J., Yang C., Zheng Y.G. Inhibitory study of protein arginine methyltransferase 1 using a fluorescent approach. Biochem Biophys Res Commun 2009, 379:567-572.
27. van de Wetering D., de Paus R.A., van Dissel J.T., van de Vosse E. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12. Int Immunol 2008, 54:90.
28. Rayamajhi M., Humann J., Penheiter K., Andreasen K., Lenz L.L. Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ. J Exp Med 2010, 207:327-337.
29. Liu B.S., Janssen H.L., Boonstra A. IL-29 and IFNalpha differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNgamma receptor expression. Blood 2011, 117:2385-2395.
30. Hua L.L., Kim M.O., Brosnan C.F., Lee S.C. Modulation of astrocyte inducible nitric oxide synthase and cytokine expression by interferon-β is associated with induction and inhibition of interferon-γ-activated sequence binding activity. J Neurochem 2002, 83:1120-1128.
31. Gao J.J., Filla M.B., Lorsbach R.B., Pace J.L., Crespo A., Russell S.W., et al. Prolonged exposure of mouse macrophages to IFN-β suppresses transcription of the inducible nitric oxide synthase gene: altered availability of transcription factor STAT1α. Eur J Immunol 2000, 30:1551-1561.
32. Ballinger M.N., Standiford T.J. Postinfluenza bacterial pneumonia: host defenses gone awry. J Interferon Cytokine Res 2010, 30:643-652.
33. Farah R., Awad J. The association of interferon with the development of pulmonary tuberculosis. Int J Clin Pharmacol Therm 2007, 45:598-600.
34. Sabbatani S., Manfredi R., Marinacci G., Pavoni M., Cristoni L., Chiodo F. Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-α and ribavirin for chronic HCV hepatitis. Scand J Infect Dis 2006, 38:205-208.
35. Telesca C., Angelico M., Piccolo P., Nosotti L., Morrone A., Longhi C., et al. Interferon-α treatment of hepatitis D induces tuberculosis exacerbation in an immigrant. J Infect 2007, 54:e223-e226.